CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

Why didn't (according to FDA) 35% of patients have their...

  1. diersel
    441 Posts.
    lightbulb Created with Sketch. 7
    clock Created with Sketch.
    25/03/10
    11:04
    Post #: 6495539
    Why didn't (according to FDA) 35% of patients have their mutation status confirmed in the data submitted in the NDA? Will this issue be addressed in the validation of the diagnostic? 35% didn't have the mutation? That is sloppy scientific reporting, isn't it?
    CXS Price at posting: 45.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?
right-arrow Created with Sketch.
AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
RZI https://hotcopper.com.au/news/asx-news/149063/fast-track-assaying-yields-182-g-t-gold-for-itech-at-new-nt-play/
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.